Genzyme = Done Deal

Well, it’s about time… Genzyme (Ticker: GENZ) has finally agreed to be acquired by Sanofi-Aventis (Ticker: SNY) for $74 in cash plus CVR (the maximum value of the CVR will be $14 in the best case scenario). I’m going to hang on to the shares until closing so I get the CVR’s. It’s been a fun and profitable journey. The game's not over and now it’s time to search for the next big trade…